Recursion Pharmaceuticals News - August 19, 2026

🟢 Recursion Pharmaceuticals is trading 10.36% up today after positive Phase 3 melanoma cancer-vaccine results

Recursion Pharmaceuticals is trading 10.36% up at $3.41, mainly as biotech stocks rallied after positive Phase 3 melanoma cancer-vaccine results from Moderna...

🟢 Recursion Pharmaceuticals rises 5.0% — Biotech Sector Surges on Positive mRNA Cancer Vaccine Trial Results

With Biotech (XBI) up 3.7%, this looks like a sector-led move rather than a company-specific surprise. The biotech sector, proxied by the XBI ETF, is trading...